HealthTree for AML(@HealthTreeAML) 's Twitter Profile Photo

is a nonprofit that provides free resources to patients and their loved ones to help them navigate their disease. Visit our website to find free resources and stay up-to-date with AML news: buff.ly/3XQFX8V
#…

#HealthTreeAML is a nonprofit that provides free resources to #AML patients and their loved ones to help them navigate their disease. Visit our website to find free resources and stay up-to-date with AML news: buff.ly/3XQFX8V
#acutemyeloidleukemia #bloodcancer #…
account_circle
Washington Post Live(@PostLive) 's Twitter Profile Photo

.Joseph Betancourt says, “If you have two patients, all things equal about them except the color of their skin, who present to an emergency room… with chest pain… minorities are significantly less likely to be referred for cardiac catheterization, angioplasty, bypass surgery.”

account_circle
HealthTree for AML(@HealthTreeAML) 's Twitter Profile Photo

Learn about and understand what causes it. Questions like 'Is it considered a cancer and are there different types?' can all be answered in this article: buff.ly/3CwRp0k

sm awareness

Learn about #MDS and understand what causes it. Questions like 'Is it considered a cancer and are there different types?' can all be answered in this article: buff.ly/3CwRp0k

#aml #amlsm #acutemyeloidleukemia #bloodcancer #bloodcancerawareness #leukemia
account_circle
Journal of Clinical Oncology(@JCO_ASCO) 's Twitter Profile Photo

💡 'Randomized Double-Blind Phase 2 Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and ' 👉 fal.cn/3zaDI

💡 'Randomized Double-Blind Phase 2 Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and #AcuteMyeloidLeukemia' 👉 fal.cn/3zaDI #AML #leusm
account_circle
OncoRelief(@OncoRelief) 's Twitter Profile Photo

In an analysis of patients (among others), vulnerability was found to have a higher impact on their compared to disease risk pubmed.ncbi.nlm.nih.gov/37146263/

account_circle
Pfizer Oncology Medical(@PfizerOncMed) 's Twitter Profile Photo

is a rare but aggressive blood cell cancer, making early diagnosis and prompt care important. This , Pfizer is raising awareness of the signs and symptoms of AML.

account_circle
Servier Pharmaceuticals(@ServierPharma) 's Twitter Profile Photo

Today, our IDH1 targeted treatment received European Commission approval for two indications: adults with newly diagnosed IDH1-mutated (AML) and adults with previously treated IDH1-mutated (CCA). Learn more: ow.ly/Y3fB50OkokA

Today, our IDH1 targeted treatment received European Commission approval for two indications: adults with newly diagnosed IDH1-mutated #acutemyeloidleukemia (AML) and adults with previously treated IDH1-mutated #cholangiocarcinoma (CCA). Learn more: ow.ly/Y3fB50OkokA
account_circle
Anne-Pierre Pickaert(@Care4Access) 's Twitter Profile Photo

Healthy vs visually explained by Pr Giovanni Marconi to Acute Leukemia Advocates Network (ALAN) members: Renoir ball dancers vs. Star Wars Stormtroopers 👉🏻 variety of bone marrow components vs. dominance of

Healthy vs #AML #bonemarrow visually explained by Pr Giovanni Marconi to @AcuteLeuk members: Renoir ball dancers vs. Star Wars Stormtroopers 👉🏻 variety of bone marrow components vs. dominance of #myeloblasts #acutemyeloidleukemia
account_circle
Actinium Pharma(@ActiniumPharma) 's Twitter Profile Photo

Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of and Other Hematologic Malignancies

ir.actiniumpharma.com/press-releases… $ATNM National Cancer Institute

Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of #AcuteMyeloidLeukemia and Other Hematologic Malignancies

ir.actiniumpharma.com/press-releases… $ATNM @theNCI
account_circle
coimmune(@CoImmune) 's Twitter Profile Photo

Philippe Leleux, Ph.D., CHU de Toulouse, created an AI program that can segment & classify bone marrow cells from people with . These tests could help improve the diagnosis of . vjhemonc.com/video/8o-gzflx… VJHemOnc

account_circle